CKCuneyt Kocas

Cuneyt Kocas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cuneyt Kocas has a total of 191 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Isolated Chronic Total Occlusion of the Left Anterior Descending Artery: The RITUAL Study

    by Sefa Sural, Claudiu Ungureanu, Abdullah Yıldırım, Vedat Aslan, Barış Düzel, Ahmet S. Gürbüz, Niyazi Görmüş, Mehmet K. Karaca, Özerdem Özçalışkan, Cüneyt Kocaş, et al.

    Background: The optimal revascularization strategy for isolated left anterior descending artery chronic total occlusion (CTO) remains uncertain, with limited comparative data between CTO percutaneous coronary intervention (CTO‐PCI) and coronary artery bypass grafting (CABG). Methods: The RITUAL (Revascularization of Isolated Chronic Total Occlusion of the Left Anterior Descending Artery) study was a retrospective, multicenter analysis conducted at 4 centers including patients who underwent revascularization for isolated left anterior descending artery CTO between January 2017 and January 2023. Lesion complexity was assessed using the Japanese Chronic Total Occlusion score. The primary end point was technical and procedural success. Secondary end points included 3‐year major adverse cardiac and cerebrovascular events and a periprocedural composite safety outcome. Multivariable Cox regression and restricted cubic spline analyses were performed. Results: Among 2382 patients treated with CTO‐PCI and 5850 surgical patients screened, 297 eligible patients (184 CTO‐PCI, 113 CABG) were analyzed. Baseline characteristics were comparable. Adjusted procedural success favored CTO‐PCI (88.6% versus 83.2%; adjusted hazard ratio [HR], 1.33 [95% CI, 1.01–1.75]; P =0.043), while technical success was similar. CABG was associated with higher rates of acute kidney injury and blood transfusion. At 3 years, all‐cause death and major adverse cardiac and cerebrovascular events were comparable. However, adjusted periprocedural composite safety outcomes were lower with CTO‐PCI (20.7% versus 35.4%; adjusted HR, 0.63 [95% CI, 0.40–0.99]; P =0.047). Increasing Japanese Chronic Total Occlusion score was linearly associated with higher major adverse cardiac and cerebrovascular event risk ( P =0.007), and among patients with a Japanese Chronic Total Occlusion score <3, periprocedural composite safety outcomes favored CTO‐PCI. Conclusions: In isolated left anterior descending artery CTO, no significant differences in 3‐year clinical outcomes were observed between CABG and CTO‐PCI, although CABG was associated with higher in‐hospital complications and CTO‐PCI with more favorable periprocedural composite safety outcomes, particularly in less complex lesions. Registration: URL: https://clinicaltrials.gov ; Unique identifier: NCT07373678.

  • Open Access

    Evaluation of lysyl oxidase G473A polymorphism with inflammatory cytokines in atherosclerotic coronary artery ectasia patients

    by Onur Kilicarslan, Ahmet Yildiz, Ozgur Selim Ser, Omer Dogan, Gulcin Ozkara, Ezgi Irmak Aslan, Hulya Yilmaz-Aydogan, Cuneyt Kocas, Mehmet Tugay Yumuk

    Objectives: Coronary artery ectasia (CAE) is characterised by an increase in the diameter of a coronary artery of ≥1.5 times its diameter at the adjacent vessel. It is evident that alterations in the extracellular matrix changes contribute to the development of CAE. Lysyl oxidases (LOXs) are copper-dependent monoamine oxidase enzymes that play a crucial role in the regulation of connective tissue. Deficiencies in these enzymes have been linked to vascular changes, consequently leading to cardiovascular diseases. The objective of this study was to assess the association between the LOX -G473A (rs1800449) variation and inflammatory markers in CAE development. Methods: The current cross-sectional study includes 88 patients whom CAE was confirmed in one of the coronary arteries by coronary angiography and 75 controls with positive exercise tests and angiographically normal coronary arteries without any typical ischemic symptoms and family history of cardiac diseases. Luminex technology was used to detect inflammatory markers. The fluorescence end-point PCR method was used for genotyping. Results: Significantly higher plasma levels of TNF-α, sE-selectin, and hypercholesterolemia were observed in the CAE group (pLOX -G473A polymorphism could be associated with the increase in inflammatory markers and CAE development.

  • Open Access

    Transkatater aort kapak implantasyonunun böbrek fonksiyonları üzerine etkisi

    by Gülsüm Bi̇ngöl, Bengisu Keski̇n Meri̇ç, Ozge Ozden Tok, Refika Hüral, Cüneyt Kocaş, Muharrem Nasi̇fov, Ahmet Yildiz, Sait Mesut Doğan, Ömer Göktekin, Barış ÖKÇÜN

    Amaç: Ciddi Aort Darlığı (AD) olan hastalarda TAVI ,aort kapak obstrüksiyonunu ortadan kaldırarak kardiyak outputu arttırır. Sol ventrikülden çıkan akımın iyileşmesi, böbreklerin kan akımını artırarak renal perfüzyonu artırır ve bozulmuş renal fonksiyonun düzelmesini sağlayabilir. Bunun yanında, TAVI sırasında kontrast madde kullanımına bağlı ya da transfemoral kateterizasyon sırasında aterom plaklarının ve kolesterol kristallerinin saçılması sonucu alt ekstremite veya renal arter embolizasyonuna bağlı akut böbrek yetersizliği gelişebilir. Bu çalışmanın amacı; TAVI’nın böbrek fonksiyonları üzerine 1. aydaki etkisini belirlemek ve hastaların eşlik eden hastalıklarının sonuca etkisi olup olmadığını saptamaktı. Gereç ve Yöntemler:Bu çalışmaya, 2015-2019 yılları arasında ciddi AD ile takip edilip TAVI yapılan toplam 68 hasta dahil edildi. Tüm hastalarda işlem öncesi ve işlemden 1 ay sonra bakılan kreatinin ve GFR değerleri cinsiyete ve eşlik eden hastalıklara göre retrospektif olarak belirlendi ve değerlendirmeler bu temelde yapıldı. Bulgular: Hastaların ortalama yaşı 78.6+7,86, ortalama sol ventrikül ejeksiyon fraksiyonu ise (LVEF ) %56.1+7,82 idi. Mevcut sonuçlar, AD’nIn düzeltilmesinden sonra 1. ayda komorbiditesi bulunan hastaların böbrek fonksiyonlarında düzelme olmadığını aksine ek hastalığı olmayan hastalara göre anlamlı derecede kreatinin değerlerinde artma ve GFR değerinde düşme olduğunu göstermektedir. Diğer komorbidite durumlarının aksine işlem öncesi kronik böbrek hastalığı olanlarda ise 1. ayda kreatinin değerlerinde anlamlı bir artış saptanmamıştır . Sonuç: Çalışmamızda işlem öncesi kronik böbrek hastalığı olan hastalarda böbrek koruması açısından daha titiz olunduğunu ve bu hastalarda kronik böbrek hastalığına sebep olan majör etkenin ciddi AD olması sebebiyle ciddi AD'nın ortadan kalkması ve buna bağlı artan kardiyak debinin böbrek fonksiyonları üzerine olumlu etki yaratarak denge sağladığını düşünüyoruz.

  • Open Access

    Incidence of atrial fibrillation and its effects on long-term follow-up outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction

    by Sukru Arslan, Istanbul- Turkey, Servet Batit, Onur Kilicarslan, Omer Dogan, Mehmet Tugay Yumuk, Seyma Arslan, Republic of Turkey Ministry of Health, Ismail Haberal, Cuneyt Kocas, et al.

    The incidence of atrial fibrillation (AF) in patients with ST segment elevation myocardial infarction (STEMI) varies between 7% and 21%, and most of these studies were in the thrombolytic era. However, the frequency of new-onset AF during the primary percutaneous coronary intervention (PCI) period is still unclear. We aimed to investigate the frequency of new-onset AF and its effects on long-term clinical events in patients undergoing primary PCI. A total of 1,603 patients who were diagnosed with STEMI and underwent primary PCI were included in the study. All the patients were monitored for at least 48 hours after the procedure. The primary endpoint of the study was defined as new-onset AF during hospitalization. The median follow-up period of our study was 44 months. New-onset AF developed in 85 (6.1%) patients. CHADs-VASc > 2, KILLIP > 2, and left atrial diameter were found to be independent predictors for the development of new-onset AF. In the AF (+) group, the all-cause and in-hospital mortality rates were found to be significantly higher. New-onset AF development in patients with STEMI was detected as an independent predictor of in-hospital mortality. In the era of primary percutaneous transluminal coronary angioplasty, new-onset AF rates were found to be lower than the literature data. In addition, new-onset AF was found to be a predictor of in-hospital mortality, and deaths occurred mostly in the early period. Therefore, close follow-up of these patients in the early period and re-evaluation in terms of AF burden when the patient becomes stable are important.


  • Treatment of LAD With Investment Procedure in a Patient With Failed CTO Attempt With TIMI 0 Flow

    by Hasan Barman, Omer Dogan, Cuneyt Kocas, Irfan Sahin

    In this case, we aimed to present a case in which TIMI 0 flow was observed in the LAD after unsuccessful PCI attempt, but was left to recover with the investment procedure and TIMI 3 flow was detected in the control angiogram. Clinical Images from Journal of Invasive Cardiology. Chronic Total Occlusion investment procedure subintimal plaque modification

  • Open Access

    The Association of Lysyl oxidase G473A Polymorphism in Coronary Artery Ectasia

    by Onur Kılıçarslan, Ahmet Yıldız, Özgür Selim Ser, Ömer Doğan, Hülya Yılmaz Akdoğan, Gülçin Özkara, Ezgi Irmak Aslan, Mehmet Tugay Yumuk, Cüneyt Koçaş

    Coronary artery ectasia (CAE) is defined by a ≥1.5-fold expansion coronary artery vessel diameter, with respect to the adjacent coronary artery vessel. Atherosclerosis and extracellular matrix changes are thought to play an important role in CAE development. Lysyl oxidase (LOX) is part of an important enzyme family involved in the regulation of connective tissue. LOX deficiency has been associated with aortic aneurysm, fold, and dissection. Our study aimed to investigate the relationship between LOX gene G473A (rs1800449) polymorphism and CAE. Eighty-eight patients diagnosed with CAE and 75 healthy individuals were included in the study. The CAE group demonstrated significantly higher hyperlipidemia (p=0.01), male sex incidence (p=0.06), serum TNF-α (p=0.03), and sE-selectin (p=0.02). The LOX genotype and allele distribution showed no significant difference between the groups. Notably, patients with CAE carrying the LOX-CT genotype demonstrated significantly higher TNF-α (p=0.04) and sP-selectin (p=0.02) levels than those carrying the LOX-CC genotype. Higher TNF-α values and hyperlipidemia were associated with the risk of CAE. Further, we observed that TNF-α levels were higher in patients with right coronary artery (RCA) ectasia. Additional large-scale studies to include other LOX gene polymorphisms may support our findings and further elucidate their relationship to CAE.


  • The association of neutrophil to lymphocyte ratio and TIMI frame count in primary percutaneous coronary intervention

    by Cuneyt Kocas, Okay Abaci, Sukru Arslan, Cem Bostan, Ugur Coskun, Faruk Akturk, Ahmet Yildiz, Murat Ersanli

    This study was sought to evaluate the relationship between admission neutrophil lymphocyte ratio (NLR) and estimated coronary flow by the TIMI frame count (TFC) method in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). TFC of 262 consecutive STEMI patients were evaluated after PPCI. Admission NLR were calculated and TFC was determined after PPCI. According to admission NLR value, patients were divided in to two groups. NLR levels higher than 3.5 were defined "higher NLR" whereas lower than 3.5 were accepted as "lower NLR". TFC was significantly higher in patients with higher NLR (56.6±41.1 vs. 37.9±36.1, P<0.001). No-reflow phenomenon was more frequent in higher NLR group compared to lower NLR group (10.1% vs. 5.2%, P=0.001). In multivariate linear regression analysis admission NLR was an independent predictor of high TIMI frame count (B=2.24 95 % CI (1.17-3.31), P<0.001). Our findings suggest that admission NLR predicts coronary blood flow in means of TFC.


  • Open Access

    Effects of ECE-1b rs213045 and rs2038089 polymorphisms on the development of contrast-induced acute kidney injury in patients with acute coronary syndrome

    by Sadiye Nur Dalgic, Hulya Yilmaz Aydogan, Oguz Ozturk, Sadrettin Pence, Deniz Kanca Demirci, Okay Abaci, Cuneyt Kocas, Yalcin Dalgic, Cem Bostan, Ahmet Yildiz

    Endothelin-1 (ET-1) promotes the progression and induction of sclerotic renal changes in end-stage kidney disease. Membrane-bound endothelin-converting enzyme 1 (ECE-1) is involved in the production of ET-1. The aim of this study was to assess the effects of ECE-1b rs213045 and rs2038089 polymorphisms, which have been shown to be involved in the development of atherosclerosis, hypertension, and nephropathy, on the development of contrast-induced acute kidney injury (CI-AKI) in patients with acute coronary syndrome. Our study included 38 patients with CI-AKI (CI-AKI[+]) and 55 patients without CI-AKI (CI-AKI[−]) who had coronary syndrome. The ECE-1b polymorphisms rs213045 and rs2038089 were assessed using real-time PCR. Serum ET-1 levels were measured by ELISA. The distributions of ECE-1b rs213045 and rs2038089 polymorphisms were similar between the two groups. Additionally, the serum ET-1 level did not different between the groups and was not associated with the ECE-1b polymorphisms. Peri-procedural low systolic blood pressure (SBP) was identified as a risk factor for CI-AKI development. Our findings indicate that ECE-1b rs213045 and rs2038089 polymorphisms are not associated with CI-AKI development and that peri-procedural low SBP is a risk factor for CI-AKI. However, variations in ECE-1b rs2038089 may contribute to the development of CI-AKI.


  • Open Access

    Correlation between breast arterial calcification and the 10-year fatal cardiovascular risk by means of the SCORE Risk System

    by Ahmet Yildiz, Seyma Yildiz, Huseyin Toprak, Cuneyt Kocas

    Objectives: The aim of this study was to investigate the relationship between Breast Arterial Calcification (BAC) on mammography and the 10-year fatal Cardiovascular Disease (CVD) risk by using SCORE risk system.Methods: The study was conducted from September 2013 to July 2014. A total of 66 women with BAC and 66 age-matched controls without BAC were analyzed. The groups were compared with respect to demographics, clinical, reproductive, laboratory parameters, and 10-year fatal CVD risk.Results: The mean ages of the women in the study was 54.0 years (40-85 years). Hypertension, systolic blood pressure, levels of serum total cholesterol and the calculated SCORE risk were higher in the BAC (+) group than in the BAC (-) group (p=0.04, p=0.031, p=0.046, and p=0.038 respectively). Multivariate analysis showed that none of them was independent factor of BAC on mammograms, only the 10-year fatal CVD risk was close to being statistically significant (OR:1.17, CI:0.98-1.38, p=0.06).Conclusion: BAC on mammography was found to be related to the 10-year fatal CVD risk as calculated by the SCORE risk score system. Additional large-scale prospective studies are required to further assess whether BAC can be considered a useful screening tool for CVD risk prediction in women who screened for breast cancer by mammography.doi: https://doi.org/10.12669/pjms.346.16031How to cite this: Yildiz A, Yildiz S, Toprak H, Kocas C. Correlation between Breast Arterial Calcification and the 10-year fatal cardiovascular risk by means of the SCORE Risk System. Pak J Med Sci. 2018;34(6):1341-1346.


  • Effect of chronic toluene exposure on heart rhythm parameters

    by Şűkrű Arslan, Isil Uzunhasan, Betul Balaban Kocas, Gokhan Cetinkal, Şeyma Arslan, Cuneyt Kocas, Okay Abaci, Mustafa Yildiz, Cengiz Celiker, Cengizhan Turkoglu

    Background: Toluene is used extensively in various industrial processes, and an increasing number of workers are getting exposed to its vapor. Cardiac abnormalities that have been reported in association with toluene exposure (in toxic doses) are atrioventricular conduction abnormalities, sinus bradycardia, ventricular tachycardia, recurrent myocardial infarction, dilated cardiomyopathy, and coronary vasospasm.Hypothesis: We aimed to investigate the effects of chronic toluene exposure on cardiac rhythm.Methods: In this study, 40 workers in the polishing industry with more than 3 months of exposure to a mixture of organic solvents including toluene and 38 control subjects working in other fields who were matched by age, sex, smoking, habits, and living accommodation were investigated. Twelve‐lead surface electrocardiogram and 24‐hour Holter recordings were performed to determine QRS duration, PR duration (P and R wave interval on electrocardiograms), P wave dispersion, corrected QT dispersion, and heart rate variability parameters.Results: The maximum heart rate was significantly lower in the toluene‐exposed group compared to the control group (130.5 ± 15.1 vs 138.6 ± 16.0, P = 0.02). Corrected low frequency (cLF) and cLF/corrected high frequency (cHF) were also significantly lower in toluene‐exposed group (43.6 ± 7.2 vs 50.7 ± 10.5, P = 0.01 and 1.4 ± 0.4 vs 2.2 ± 1.0, P < 0.01, respectively). Mean cHF, root‐mean‐square successive difference, and standard deviation of all five‐minute NN interval means values were significantly higher in the toluene‐exposed group (32.8 ± 8.1 vs 25.4 ± 8.2, P ≤ 0.01; 74.0 ± 46.1 vs 60.3 ± 59.4, P = 0.02; and 149.5 ± 77.0 vs 108.9 ± 43.2, P = 0.01, respectively).Conclusions: This study implies that chronic toluene exposure disturbs cardiac autonomy, particularly by suppressing sympathetic activity, and parasympathetic suppression also occurs with increased exposure duration. We also demonstrated that chronic toluene exposure was not associated with major cardiac arrhythmias and rhythm conduction system disorders.